Furthermore, in human cancer cells, IDO1 has been implicated in improving DNA repair and mediating resistance to treatments, such as the PARP inhibitor olaparib, γ-radiation, and the chemotherapeutic agent cisplatin, by production of NAD+ [42]. Here, IDO1 is linked to cancer.